Outlook Therapeutics公司宣布将利用新发行票据所筹集的资金,用于偿还部分现有票据债务。经此操作后,该公司现有票据未偿还本金及利息余额仍达1080万美元。
Outlook Therapeutics公司宣布将利用新发行票据所筹集的资金,用于偿还部分现有票据债务。经此操作后,该公司现有票据未偿还本金及利息余额仍达1080万美元。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.